SGLT2 inhibitors alleviated podocyte damage in lupus nephritis by decreasing inflammation and enhancing autophagy.

Saved in:
Bibliographic Details
Title: SGLT2 inhibitors alleviated podocyte damage in lupus nephritis by decreasing inflammation and enhancing autophagy.
Authors: Zhao XY; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.; Zhengzhou University, Zhengzhou, Henan, China., Li SS; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.; Zhengzhou University, Zhengzhou, Henan, China.; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.; Ministry of Education of China, Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou, Henan, China., He YX; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.; Zhengzhou University, Zhengzhou, Henan, China.; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.; Ministry of Education of China, Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou, Henan, China., Yan LJ; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.; Zhengzhou University, Zhengzhou, Henan, China.; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.; Ministry of Education of China, Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou, Henan, China., Lv F; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.; Zhengzhou University, Zhengzhou, Henan, China., Liang QM; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.; Zhengzhou University, Zhengzhou, Henan, China., Gan YH; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.; Zhengzhou University, Zhengzhou, Henan, China.; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.; Ministry of Education of China, Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou, Henan, China., Han LP; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.; Zhengzhou University, Zhengzhou, Henan, China., Xu HD; Zhengzhou University, Zhengzhou, Henan, China.; Ministry of Education of China, Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou, Henan, China., Li YC; Zhengzhou University, Zhengzhou, Henan, China.; Ministry of Education of China, Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou, Henan, China., Qi YY; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China qqyyiillyy@126.com.; Zhengzhou University, Zhengzhou, Henan, China.; Laboratory of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou Henan, China.
Source: Annals of the rheumatic diseases [Ann Rheum Dis] 2023 Oct; Vol. 82 (10), pp. 1328-1340. Date of Electronic Publication: 2023 Jul 24.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 0372355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2060 (Electronic) Linking ISSN: 00034967 NLM ISO Abbreviation: Ann Rheum Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1468-2060
DOI:10.1136/ard-2023-224242